<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03733899</url>
  </required_header>
  <id_info>
    <org_study_id>CR-6292</org_study_id>
    <nct_id>NCT03733899</nct_id>
  </id_info>
  <brief_title>An Investigation of the Impact of Localized Topical Anesthesia of the Ocular Surface on End-of-day Contact Lens Discomfort</brief_title>
  <official_title>An Investigation of the Impact of Localized Topical Anesthesia of the Ocular Surface on End-of-day Contact Lens Discomfort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a controlled, randomized, subject-masked, 3x3 crossover, non-dispensing,
      contralateral study. Twenty subjects will be recruited based on their scores (with their
      habitual lenses) from the Contact Lens Dry Eye Questionnaire-8 and examined on four
      occasions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 7, 2018</start_date>
  <completion_date type="Actual">February 7, 2019</completion_date>
  <primary_completion_date type="Actual">February 7, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective Comfort Scores</measure>
    <time_frame>5 and 10 Minutes post-treament</time_frame>
    <description>Subjects were asked to rate how comfortable each eye was overall using a visual analog scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Subjective Comfort Scores From Pre-treatment to Post-treatment</measure>
    <time_frame>14-Hours upon Lens-Insertion (pre-treatment), and 10 Minutes post-treament</time_frame>
    <description>Subjects were asked to rate how comfortable each eye was overall using a visual analog scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable. Subjects wore their habitual contacts during the pre-treatment assessment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Comfort Score Difference Between Post-treatment and Post-insertion Within Anesthetic</measure>
    <time_frame>Immediately after lens-insertion, 5 and 10 minutes post-treatment</time_frame>
    <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Subjective Comfort Between Ocular Regions at Posttreatment Within Anesthetic</measure>
    <time_frame>5 and 10 minutes post treatment</time_frame>
    <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Subjective Comfort From Pre-treatment to Post-Treatment Between Ocular Regions</measure>
    <time_frame>14 hours upon lens-insertion (pre-treatment), 5- and 10- minutes post-treatment</time_frame>
    <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Comfort Difference Between Post-removal and Preinsertion Within Anesthetic and Cornea</measure>
    <time_frame>Immediately before lens-insertion (pre-insertion), 30 seconds after lens removal</time_frame>
    <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Visual Acuity</condition>
  <arm_group>
    <arm_group_label>Upper lid margin/Lower lid margin/Cornea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects that are at least 18 years of age wearing their habitual lenses will be randomized into one of six unique sequences of an ocular surface region. For each region within a sequence, the two treatments will be randomly assigned to the left and right eye (anesthesia left eye/placebo right eye OR placebo left eye/anesthesia left eye).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lower lid margin/Cornea/ Upper lid margin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects that are at least 18 years of age wearing their habitual lenses will be randomized into one of six unique sequences. For each region within a sequence, the two treatments will be randomly assigned to the left and right eye (anesthesia left eye/placebo right eye OR placebo left eye/anesthesia left eye).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cornea/Upper lid margin/Lower lid margin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects that are at least 18 years of age wearing their habitual lenses will be randomized into one of six unique sequences. For each region within a sequence, the two treatments will be randomly assigned to the left and right eye (anesthesia left eye/placebo right eye OR placebo left eye/anesthesia left eye).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cornea/Lower lid margin/Upper lid margin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects that are at least 18 years of age wearing their habitual lenses will be randomized into one of six unique sequences. For each region within a sequence, the two treatments will be randomly assigned to the left and right eye (anesthesia left eye/placebo right eye OR placebo left eye/anesthesia left eye).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Upper lid margin/Cornea/Lower lid margin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects that are at least 18 years of age wearing their habitual lenses will be randomized into one of six unique sequences. For each region within a sequence, the two treatments will be randomly assigned to the left and right eye (anesthesia left eye/placebo right eye OR placebo left eye/anesthesia left eye).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lower lid margin/Upper lid margin/Cornea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects that are at least 18 years of age wearing their habitual lenses will be randomized into one of six unique sequences. For each region within a sequence, the two treatments will be randomly assigned to the left and right eye (anesthesia left eye/placebo right eye OR placebo left eye/anesthesia left eye).</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Local Anesthesia</intervention_name>
    <description>Minims Proxymetacaine hydrochloride Eye Drops</description>
    <arm_group_label>Cornea/Lower lid margin/Upper lid margin</arm_group_label>
    <arm_group_label>Cornea/Upper lid margin/Lower lid margin</arm_group_label>
    <arm_group_label>Lower lid margin/Cornea/ Upper lid margin</arm_group_label>
    <arm_group_label>Lower lid margin/Upper lid margin/Cornea</arm_group_label>
    <arm_group_label>Upper lid margin/Cornea/Lower lid margin</arm_group_label>
    <arm_group_label>Upper lid margin/Lower lid margin/Cornea</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Sodium Chloride Solution</description>
    <arm_group_label>Cornea/Lower lid margin/Upper lid margin</arm_group_label>
    <arm_group_label>Cornea/Upper lid margin/Lower lid margin</arm_group_label>
    <arm_group_label>Lower lid margin/Cornea/ Upper lid margin</arm_group_label>
    <arm_group_label>Lower lid margin/Upper lid margin/Cornea</arm_group_label>
    <arm_group_label>Upper lid margin/Cornea/Lower lid margin</arm_group_label>
    <arm_group_label>Upper lid margin/Lower lid margin/Cornea</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Potential subjects must satisfy all of the following criteria to be enrolled in the
             study:

               1. They are of legal age (18 years) and capacity of volunteer.

               2. The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and
                  receive a fully executed copy of the form.

               3. They must appear able and willing to adhere to the instructions set forth in this
                  clinical protocol.

               4. They have worn the same brand of soft spherical contact lenses for at least the
                  previous three months, by self-report.

               5. They are defined as 'symptomatic' contact lens wearers (CLDEQ-8 score of 20-37)
                  with their habitual contact lenses.

               6. They are willing to wear their lenses for approximately 14 hours on study days.

               7. They have a wearable pair of spectacles, if applicable.

               8. They agree not to participate in other clinical research for the duration of this
                  study.

               9. They can attain high contrast logMAR visual acuity of 0.20 or better in their
                  habitual contact lenses in each eye.

                  Exclusion Criteria:

          -  Potential subjects who meet any of the following criteria will be excluded from
             participating in the study:

               1. They have an ocular disorder, which would normally contra-indicate contact lens
                  wear.

               2. They have a systemic disorder, which would normally contra-indicate contact lens
                  wear.

               3. They are using any topical medication such as eye drops or ointment.

               4. They have had cataract or corneal refractive surgery.

               5. They are pregnant or breast-feeding by self-report.

               6. They have any infectious disease (e.g. hepatitis) or any immunosuppressive
                  disease (e.g. HIV), by self-report.

               7. They have any known hypersensitivity or allergic reaction to any of the known
                  ingredients in the anesthetic.

               8. They have a history of severe allergic reaction or anaphylaxis.

               9. They have a history of cardiac disease or hyperthyroidism.

              10. They have taken part in any other contact lens or care solution clinical trial or
                  research, within two weeks prior to starting this study.

              11. They are an employee or immediate family member of an employee of clinical site
                  (e.g., Investigator, Coordinator, Technician).

              12. They have any corneal distortion resulting from previous hard or rigid lens wear
                  or have keratoconus.

              13. They have grade 3 or greater of any of the following ocular surface signs which
                  would contraindicate contact lens wear: corneal edema, corneal vascularisation,
                  corneal staining, tarsal conjunctival changes or any other abnormality which
                  would normally contraindicate contact lens wear.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The University of Manchester</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 6, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2018</study_first_posted>
  <results_first_submitted>January 24, 2020</results_first_submitted>
  <results_first_submitted_qc>January 24, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 6, 2020</results_first_posted>
  <last_update_submitted>February 28, 2020</last_update_submitted>
  <last_update_submitted_qc>February 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 24, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/99/NCT03733899/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 22 subjects were enrolled in this study. Of those enrolled, 20 were dispensed at least one study lens while 2 subjects failed to meet all eligibility criteria. Of those dispensed, 17 completed the study while 3 subjects were discontinued.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Lower Lid Margin/Upper Lid Margin/Cornea</title>
          <description>Subjects assigned to recieved two treatmens contralaterally, in the lower lid margin during period 1, the upper lid margin during period 2 and the cornea at period 3.</description>
        </group>
        <group group_id="P2">
          <title>Lower Lid Margin/Cornea/Upper Lid Margin</title>
          <description>Subjects assigned to recieved two treatmens contralaterally, in the lower lid margin during period 1, the cornea during period 2 and the upper lid margin during period 3.</description>
        </group>
        <group group_id="P3">
          <title>Upper Lid Margin/Lower Lid Margin/Cornea</title>
          <description>Subjects assigned to recieved two treatmens contralaterally, in the upper lid margin during period 1, the lower lid margin during period 2 and the cornea during period 3.</description>
        </group>
        <group group_id="P4">
          <title>Upper Lid Margin/Cornea/Lower Lid Margin</title>
          <description>Subjects assigned to recieved two treatmens contralaterally, in the upper lid margin during period 1, the cornea during period 2 and the lower lid margin during period 3.</description>
        </group>
        <group group_id="P5">
          <title>Cornea/Lower Lid Margin/Upper Lid Margin</title>
          <description>Subjects assigned to recieved two treatmens contralaterally, in the Cornea during period 1, the lower lid margin during period 2 and the upper lid maring during period 3.</description>
        </group>
        <group group_id="P6">
          <title>Cornea/Upper Lid Margin/Lower Lid Margin</title>
          <description>Subjects assigned to recieved two treatmens contralaterally, in the Cornea during period 1, the upper lid margin during period 2 and the lower lid maring during period 3.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Period 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Unscuccessful Treatment</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Period 3</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Dispensed Subjects</title>
          <description>All subjects dispensed at least one study lens.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.2" spread="70.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Count of Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African Amercian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Subjective Comfort Scores</title>
        <description>Subjects were asked to rate how comfortable each eye was overall using a visual analog scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
        <time_frame>5 and 10 Minutes post-treament</time_frame>
        <population>All randomized subjects regardless of actual treatment and subsequent withdrawl from the study or deviation from protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (Anesthetic)- Cornea</title>
            <description>Eyes that instilled the Test (Anesthetic) in either the right or left corneal ocular region.</description>
          </group>
          <group group_id="O2">
            <title>Placebo- Cornea</title>
            <description>Eyes that instilled the Placebo in either the right or left corneal ocular region.</description>
          </group>
          <group group_id="O3">
            <title>Test (Anesthetic) - Upper Lid Margin</title>
            <description>Eyes that instilled the Test in either the right or left upper lid margin.</description>
          </group>
          <group group_id="O4">
            <title>Placebo- Upper Lid Margin</title>
            <description>Eyes that instilled the Placebo in either the right or left upper lid margin.</description>
          </group>
          <group group_id="O5">
            <title>Test (Anesthetic)- Lower Lid Margin</title>
            <description>Eyes that instilled the Test in either the right or left lower lid margin.</description>
          </group>
          <group group_id="O6">
            <title>Placebo- Lower Lid Margin</title>
            <description>Eyes that instilled the Placebo in either the right or left lower lid margin.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Comfort Scores</title>
          <description>Subjects were asked to rate how comfortable each eye was overall using a visual analog scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
          <population>All randomized subjects regardless of actual treatment and subsequent withdrawl from the study or deviation from protocol.</population>
          <units>Units on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="18"/>
                <count group_id="O4" value="17"/>
                <count group_id="O5" value="19"/>
                <count group_id="O6" value="18"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="18"/>
                <count group_id="O4" value="17"/>
                <count group_id="O5" value="19"/>
                <count group_id="O6" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>5- Mintues Post Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.25" spread="8.925"/>
                    <measurement group_id="O2" value="70.93" spread="20.838"/>
                    <measurement group_id="O3" value="61.00" spread="20.807"/>
                    <measurement group_id="O4" value="61.94" spread="16.783"/>
                    <measurement group_id="O5" value="64.00" spread="20.915"/>
                    <measurement group_id="O6" value="61.06" spread="21.292"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10- Mintues Post Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.50" spread="10.265"/>
                    <measurement group_id="O2" value="72.33" spread="20.430"/>
                    <measurement group_id="O3" value="65.11" spread="21.766"/>
                    <measurement group_id="O4" value="64.00" spread="19.239"/>
                    <measurement group_id="O5" value="70.79" spread="16.511"/>
                    <measurement group_id="O6" value="63.17" spread="20.667"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>5-Mintues Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-Square Mean Difference</param_type>
            <param_value>2.6</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.96</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7.3</ci_lower_limit>
            <ci_upper_limit>12.4</ci_upper_limit>
            <estimate_desc>Difference was calculated as Test - Placebo</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>10-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-square Mean Difference</param_type>
            <param_value>0.9</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.30</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.6</ci_lower_limit>
            <ci_upper_limit>11.5</ci_upper_limit>
            <estimate_desc>Difference was calculated as Test - Placebo</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>5-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-Square Mean Difference</param_type>
            <param_value>0.8</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.67</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.2</ci_lower_limit>
            <ci_upper_limit>9.8</ci_upper_limit>
            <estimate_desc>difference was calculated as Test - Placebo.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>10-Mintues Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-square Mean Difference</param_type>
            <param_value>2.9</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.67</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.5</ci_lower_limit>
            <ci_upper_limit>12.2</ci_upper_limit>
            <estimate_desc>Difference was calculated as Test - Placebo.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>5-Mintues Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-square Mean Difference</param_type>
            <param_value>3.0</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.37</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.7</ci_lower_limit>
            <ci_upper_limit>11.7</ci_upper_limit>
            <estimate_desc>Difference was calculated as Test - Placebo.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>10-Mintues Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-sqaure Mean Difference</param_type>
            <param_value>7.7</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.54</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.4</ci_lower_limit>
            <ci_upper_limit>16.8</ci_upper_limit>
            <estimate_desc>difference was calculated as Test - Placebo.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Subjective Comfort Scores From Pre-treatment to Post-treatment</title>
        <description>Subjects were asked to rate how comfortable each eye was overall using a visual analog scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable. Subjects wore their habitual contacts during the pre-treatment assessment.</description>
        <time_frame>14-Hours upon Lens-Insertion (pre-treatment), and 10 Minutes post-treament</time_frame>
        <population>All randomized subjects regardless of actual treatment and subsequent withdrawl from the study or deviation from protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (Anesthetic)- Cornea</title>
            <description>Eyes that instilled the Test (Anesthetic) in either the right or left corneal ocular region.</description>
          </group>
          <group group_id="O2">
            <title>Placebo- Cornea</title>
            <description>Eyes that instilled the Placebo in either the right or left corneal ocular region.</description>
          </group>
          <group group_id="O3">
            <title>Test (Anesthetic) - Upper Lid Margin</title>
            <description>Eyes that instilled the Test in either the right or left upper lid margin.</description>
          </group>
          <group group_id="O4">
            <title>Placebo- Upper Lid Margin</title>
            <description>Eyes that instilled the Placebo in either the right or left upper lid margin.</description>
          </group>
          <group group_id="O5">
            <title>Test (Anesthetic)- Lower Lid Margin</title>
            <description>Eyes that instilled the Test in either the right or left lower lid margin.</description>
          </group>
          <group group_id="O6">
            <title>Placebo- Lower Lid Margin</title>
            <description>Eyes that instilled the Placebo in either the right or left lower lid margin.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Subjective Comfort Scores From Pre-treatment to Post-treatment</title>
          <description>Subjects were asked to rate how comfortable each eye was overall using a visual analog scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable. Subjects wore their habitual contacts during the pre-treatment assessment.</description>
          <population>All randomized subjects regardless of actual treatment and subsequent withdrawl from the study or deviation from protocol.</population>
          <units>Units on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="18"/>
                <count group_id="O4" value="17"/>
                <count group_id="O5" value="19"/>
                <count group_id="O6" value="18"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="18"/>
                <count group_id="O4" value="17"/>
                <count group_id="O5" value="19"/>
                <count group_id="O6" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>5- Mintues Post Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.25" spread="8.925"/>
                    <measurement group_id="O2" value="70.93" spread="20.838"/>
                    <measurement group_id="O3" value="61.00" spread="20.807"/>
                    <measurement group_id="O4" value="61.94" spread="16.783"/>
                    <measurement group_id="O5" value="64.00" spread="20.915"/>
                    <measurement group_id="O6" value="61.06" spread="21.292"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10- Mintues Post Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.50" spread="10.265"/>
                    <measurement group_id="O2" value="72.33" spread="20.430"/>
                    <measurement group_id="O3" value="65.11" spread="21.766"/>
                    <measurement group_id="O4" value="64.00" spread="19.239"/>
                    <measurement group_id="O5" value="70.79" spread="16.511"/>
                    <measurement group_id="O6" value="63.17" spread="20.667"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pre-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.35" spread="23.238"/>
                    <measurement group_id="O2" value="60.16" spread="24.862"/>
                    <measurement group_id="O3" value="56.67" spread="24.867"/>
                    <measurement group_id="O4" value="58.35" spread="24.746"/>
                    <measurement group_id="O5" value="60.11" spread="24.669"/>
                    <measurement group_id="O6" value="57.94" spread="21.939"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>5-Mintues Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-Square Mean Difference</param_type>
            <param_value>2.1</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>6.22</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-10.3</ci_lower_limit>
            <ci_upper_limit>14.4</ci_upper_limit>
            <estimate_desc>Difference was calculated as Test - Placebo</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>10-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-square Mean Difference</param_type>
            <param_value>0.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>6.30</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-12.1</ci_lower_limit>
            <ci_upper_limit>12.9</ci_upper_limit>
            <estimate_desc>Difference was calculated as Test - Placebo</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>5-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-Square Mean Difference</param_type>
            <param_value>0.3</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.92</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-11.4</ci_lower_limit>
            <ci_upper_limit>12.1</ci_upper_limit>
            <estimate_desc>difference was calculated as Test - Placebo.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>10-Mintues Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-square Mean Difference</param_type>
            <param_value>2.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.83</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.2</ci_lower_limit>
            <ci_upper_limit>14.0</ci_upper_limit>
            <estimate_desc>Difference was calculated as Test - Placebo.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>5-Mintues Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-square Mean Difference</param_type>
            <param_value>2.9</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.76</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.5</ci_lower_limit>
            <ci_upper_limit>14.3</ci_upper_limit>
            <estimate_desc>Difference was calculated as Test - Placebo.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>10-Mintues Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Least-sqaure Mean Difference</param_type>
            <param_value>7.6</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.67</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.7</ci_lower_limit>
            <ci_upper_limit>18.8</ci_upper_limit>
            <estimate_desc>difference was calculated as Test - Placebo.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Comfort Score Difference Between Post-treatment and Post-insertion Within Anesthetic</title>
        <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
        <time_frame>Immediately after lens-insertion, 5 and 10 minutes post-treatment</time_frame>
        <population>All randomized subjects regardless of actual treatment and subsequent withdrawal from study or deviation from protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (Anesthetic)- Corneal</title>
            <description>Eyes that instilled the Test (Anesthetic) in either the right or left corneal ocular region.</description>
          </group>
          <group group_id="O2">
            <title>Test (Anesthetic) - Upper Lid Margin</title>
            <description>Eyes that instilled the Test in either the right or left upper lid margin.</description>
          </group>
          <group group_id="O3">
            <title>Test (Anesthetic)- Lower Lid Margin</title>
            <description>Eyes that instilled the Test in either the right or left lower lid margin.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Comfort Score Difference Between Post-treatment and Post-insertion Within Anesthetic</title>
          <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
          <population>All randomized subjects regardless of actual treatment and subsequent withdrawal from study or deviation from protocol.</population>
          <units>Units on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Immediate Post Lens Insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.06" spread="17.243"/>
                    <measurement group_id="O2" value="73.33" spread="22.646"/>
                    <measurement group_id="O3" value="80.37" spread="14.064"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5-Minutes Post Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.25" spread="8.925"/>
                    <measurement group_id="O2" value="61.00" spread="20.807"/>
                    <measurement group_id="O3" value="64.00" spread="20.915"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 Minutes Post Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.50" spread="10.265"/>
                    <measurement group_id="O2" value="65.11" spread="21.766"/>
                    <measurement group_id="O3" value="70.79" spread="16.511"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>5-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0 for at least one of the three ocular regions (upper lid margin, lower lid margin, or cornea).</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-4.0</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.61</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-13.2</ci_lower_limit>
            <ci_upper_limit>5.1</ci_upper_limit>
            <other_analysis_desc>Mean difference was calculated as (5-min Post-Treatment MINUS Immediate Post-insertion).</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>10-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0 for at least one of the three ocular regions (upper lid margin, lower lid margin, or cornea).</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-4.3</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.85</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-13.9</ci_lower_limit>
            <ci_upper_limit>5.3</ci_upper_limit>
            <other_analysis_desc>Mean difference was calculated as (10-min Post-Treatment MINUS Immediate Post-insertion).</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>5-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0 for at least one of the three ocular regions (upper lid margin, lower lid margin, or cornea).</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-16.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.04</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-24.4</ci_lower_limit>
            <ci_upper_limit>-8.3</ci_upper_limit>
            <other_analysis_desc>Mean difference was calculated as (5-min Post-Treatment MINUS Immediate Post-insertion).</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>10-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0 for at least one of the three ocular regions (upper lid margin, lower lid margin, or cornea).</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-9.6</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.14</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-17.8</ci_lower_limit>
            <ci_upper_limit>-1.4</ci_upper_limit>
            <other_analysis_desc>Mean difference was calculated as (10-min Post-Treatment MINUS Immediate Post-insertion).</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>5-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0 for at least one of the three ocular regions (upper lid margin, lower lid margin, or cornea).</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-12.3</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.15</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-20.6</ci_lower_limit>
            <ci_upper_limit>-4.1</ci_upper_limit>
            <other_analysis_desc>Mean difference was calculated as (5-min Post-Treatment MINUS Immediate Post-insertion).</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>10-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0 for at least one of the three ocular regions (upper lid margin, lower lid margin, or cornea).</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-8.2</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.25</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-16.7</ci_lower_limit>
            <ci_upper_limit>0.2</ci_upper_limit>
            <other_analysis_desc>Mean difference was calculated as (10-min Post-Treatment MINUS Immediate Post-insertion).</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Subjective Comfort Between Ocular Regions at Posttreatment Within Anesthetic</title>
        <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
        <time_frame>5 and 10 minutes post treatment</time_frame>
        <population>All randomized subjects regardless of actual treatment and subsequent withdrawal from study or deviation from protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (Anesthetic)- Corneal</title>
            <description>Eyes that instilled the Test (Anesthetic) in either the right or left corneal ocular region.</description>
          </group>
          <group group_id="O2">
            <title>Test (Anesthetic) - Upper Lid Margin</title>
            <description>Eyes that instilled the Test in either the right or left upper lid margin.</description>
          </group>
          <group group_id="O3">
            <title>Test (Anesthetic)- Lower Lid Margin</title>
            <description>Eyes that instilled the Test in either the right or left lower lid margin.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Subjective Comfort Between Ocular Regions at Posttreatment Within Anesthetic</title>
          <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
          <population>All randomized subjects regardless of actual treatment and subsequent withdrawal from study or deviation from protocol.</population>
          <units>Units on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>5-Minutes Post Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.25" spread="8.925"/>
                    <measurement group_id="O2" value="61.00" spread="20.807"/>
                    <measurement group_id="O3" value="64.00" spread="20.915"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 Minutes Post Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.50" spread="10.265"/>
                    <measurement group_id="O2" value="65.11" spread="21.766"/>
                    <measurement group_id="O3" value="70.79" spread="16.511"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>10-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.07</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.7</ci_lower_limit>
            <ci_upper_limit>11.6</ci_upper_limit>
            <other_analysis_desc>Mean Difference was cacluated as Corneal - Lower Lid Margin</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>5-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>8.5</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.77</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.0</ci_lower_limit>
            <ci_upper_limit>18.0</ci_upper_limit>
            <other_analysis_desc>Mean Difference was cacluated as Corneal - Lower Lid Margin</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>10-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>6.8</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.12</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.5</ci_lower_limit>
            <ci_upper_limit>17.0</ci_upper_limit>
            <other_analysis_desc>Mean Difference was cacluated as Corneal - Upper Lid Margin</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>5-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>11.2</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.82</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.6</ci_lower_limit>
            <ci_upper_limit>20.8</ci_upper_limit>
            <other_analysis_desc>Mean Difference was cacluated as Corneal - Upper Lid Margin</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Subjective Comfort From Pre-treatment to Post-Treatment Between Ocular Regions</title>
        <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
        <time_frame>14 hours upon lens-insertion (pre-treatment), 5- and 10- minutes post-treatment</time_frame>
        <population>All randomized subjects regardless of actual treatment and subsequent withdrawal from study or deviation from protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (Anesthetic)- Corneal</title>
            <description>Eyes that instilled the Test (Anesthetic) in either the right or left corneal ocular region.</description>
          </group>
          <group group_id="O2">
            <title>Test (Anesthetic) - Upper Lid Margin</title>
            <description>Eyes that instilled the Test in either the right or left upper lid margin.</description>
          </group>
          <group group_id="O3">
            <title>Test (Anesthetic)- Lower Lid Margin</title>
            <description>Eyes that instilled the Test in either the right or left lower lid margin.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Subjective Comfort From Pre-treatment to Post-Treatment Between Ocular Regions</title>
          <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
          <population>All randomized subjects regardless of actual treatment and subsequent withdrawal from study or deviation from protocol.</population>
          <units>Units on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.35" spread="23.238"/>
                    <measurement group_id="O2" value="56.67" spread="24.867"/>
                    <measurement group_id="O3" value="60.16" spread="24.862"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5-Minutes Post Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.25" spread="8.925"/>
                    <measurement group_id="O2" value="61.00" spread="20.807"/>
                    <measurement group_id="O3" value="64.00" spread="20.915"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10-Minutes Post Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.50" spread="10.265"/>
                    <measurement group_id="O2" value="65.11" spread="21.766"/>
                    <measurement group_id="O3" value="70.79" spread="16.511"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>10-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.8</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>6.12</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-11.4</ci_lower_limit>
            <ci_upper_limit>12.9</ci_upper_limit>
            <other_analysis_desc>Mean Difference was cacluated as Corneal - Lower Lid Margin: 10-mintues post treatment - Pre Treatment.</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>5-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>7.8</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>6.10</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.9</ci_lower_limit>
            <ci_upper_limit>19.9</ci_upper_limit>
            <other_analysis_desc>Mean Difference was cacluated as Corneal - Lower Lid Margin: 5-mintues post treatment - Pre Treatment.</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>10-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>2.9</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>6.19</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.3</ci_lower_limit>
            <ci_upper_limit>15.2</ci_upper_limit>
            <other_analysis_desc>Mean Difference was cacluated as Corneal - Upper Lid Margin: 10-mintues post treatment - Pre Treatment.</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>5-Minutes Post Treatment</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Subjective comfort was analyzed using linear mixed model. Statistical inference was made based on the 95% confidence interval constructed for the least square mean difference.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>7.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>6.17</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.9</ci_lower_limit>
            <ci_upper_limit>19.6</ci_upper_limit>
            <other_analysis_desc>Mean Difference was cacluated as Corneal - Upper Lid Margin: 5-mintues post treatment - Pre Treatment.</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Comfort Difference Between Post-removal and Preinsertion Within Anesthetic and Cornea</title>
        <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
        <time_frame>Immediately before lens-insertion (pre-insertion), 30 seconds after lens removal</time_frame>
        <population>All randomized subjects regardless of actual treatment and subsequent withdrawl from study or deviation from protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (Anesthetic)- Cornea</title>
            <description>Eyes that instilled the Test (Anesthetic) in either the right or left corneal ocular region.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Comfort Difference Between Post-removal and Preinsertion Within Anesthetic and Cornea</title>
          <description>Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.</description>
          <population>All randomized subjects regardless of actual treatment and subsequent withdrawl from study or deviation from protocol.</population>
          <units>Units on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.53" spread="17.784"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.12" spread="21.508"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was concluded if the lower limit of 95% confidence interval was greater than 0.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-12.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.22</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-20.9</ci_lower_limit>
            <ci_upper_limit>-3.9</ci_upper_limit>
            <other_analysis_desc>mean difference was calculated as postremoval minus pre-insertion with Test and corneal region.</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Throughout the entire duration of the study. Up to 6-weeks per subject.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>subjects that were exposed to the placebo during any point in the study.</description>
        </group>
        <group group_id="E2">
          <title>Test (Anesthetic)</title>
          <description>Subjects that were exposed to the Anesthetic during any point in the study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Thomas Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist</name_or_title>
      <organization>Johnson &amp; Johnson Vision Care, Inc.</organization>
      <phone>904-443-3402</phone>
      <email>TKarkkai@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

